Evidence map›Paper›PMID 38203288›Full record

ArticleInternational journal of molecular sciences2023

Maria Teresa Bochicchio, Giovanni Marconi, Carmen Baldazzi, Lorenza Bandini, Francesca Ruggieri, Alessandro Lucchesi, Claudio Agostinelli, Elena Sabattini, Agnese Orsatti, Anna Ferrari and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. [Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Maria Teresa BochicchioBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0001-9299-9189
Giovanni MarconiHematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0001-6309-0515
Carmen BaldazziIstituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.ORCID 0000-0003-3796-6418
Lorenza BandiniIstituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Francesca RuggieriBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0002-4330-6320
Alessandro LucchesiHematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0002-0624-5311
Claudio AgostinelliDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy.
Elena SabattiniHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.ORCID 0000-0002-4136-3591
Agnese OrsattiHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Anna FerrariBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0002-7022-9906
Giorgia CapirossiBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.
Chiara ServiliBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.
Andrea Ghelli Luserna di RoràFondazione Pisana per la Scienza ONLUS, 56017 San Giuliano Terme, PI, Italy.
Giovanni MartinelliScientific Directorate, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0002-1025-4210
Giorgia SimonettiBiosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.ORCID 0000-0001-6954-969X
Gianantonio RostiHematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori", 47014 Meldola, FC, Italy.
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITAzienda USL di Bologna · ITIstituto di Ematologia di Bologna · ITFondazione Pisa · IT

Funding

Italian Ministry of Health Ricerca Corrente within the research line "Precision, gender and ethnicity-based medicine and geroscience: genet-ic-molecular mechanisms in the development, characterization and treatment of tumors"Italian Ministry of Health Ricerca Finalizzata GR-2018-12365278
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hypereosinophilic SyndromeMyeloproliferative DisordersNeoplasmsCytogeneticsFemaleHumansImatinib MesylateMiddle AgedProtein Kinase InhibitorsProto-Oncogene Proteins c-etsImatinib MesylateProtein Kinase InhibitorsProto-Oncogene Proteins c-etsdiagnostic RNA panelsETV6::ABL1fusion genesimatinib mesylatemyeloid/lymphoid neoplasmnext generation sequencing

Identifiers

PMID38203288
PMCPMC10779409
OpenAlexW4390054034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.